L3VLUP
ProSign in

SRRK in the 13F filings

Scholar Rock HLDG Corp · CUSIP 80706P103

Sector · Pharmaceuticals and biotechnologyTheme · Biological productsTheme · Healthcare: biopharma and medtech· L3VLUP-defined
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
31 Dec 2023
the date the book describes
Filed
16 Feb 2024
latest of these filings; the earliest 14 Feb 2024
Managers listing it
3
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q3 2023 and Q4 2023; 1 listed it in both
Shares listed
10,378,022
combined, among listed positions
Reported value
$195m
combined, at the quarter end

Among the 93 comparable managers: 3 buyers (opened or added shares) and 1 seller (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing SRRK in Q4 2023

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2023, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

3 of 3 holders

ActionFiling
T. Rowe Price Associates Inc8,321,471$156munder 0.1%Addedn.a.16 Feb 2024 (the filing on sec.gov)
Point72 Asset Management LP1,131,668$21m0.05%Newnew14 Feb 2024 (the filing on sec.gov)
Woodline Partners LP924,883$17m0.19%Added+409,26714 Feb 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q3 2023 to Q4 2023, among managers that listed it in both quarters or opened it.

Increases

Reductions

No reduction among listed positions.

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Exited (1)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
1 in Q3 2024 to 9 in Q2 2026

Tracked managers listing it, at least.

05101520202021202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
SRRK by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20181$1.2mn.a.n.a.
Q3 20191$895kn.a.n.a.
Q4 20191$1.8mn.a.n.a.
Q1 20202$5.4mn.a.n.a.
Q2 20201$1.8mn.a.n.a.
Q3 20202$2.5mn.a.n.a.
Q4 20202$9.4mn.a.n.a.
Q1 20211$7.0mn.a.n.a.
Q2 20211$3.9mn.a.n.a.
Q3 20211$4.5mn.a.n.a.
Q2 20222$3.9mn.a.n.a.
Q3 20221$508kn.a.n.a.
Q4 20221$277kn.a.n.a.
Q2 20232$3.8mn.a.n.a.
Q3 20232$4.1mn.a.n.a.
Q4 20233$195m31
Q1 20242$165m11
Q2 20241$5.9m01
Q3 20241$5.7m10
Q4 20248$1.2bn71
Q1 20258$933m43
Q2 20259$1.1bn52
Q3 202511$1.3bn63
Q4 202510$1.5bn1710
Q1 202610$1.9bn189
Q2 20269$2.2bn1415

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

SRRK and GILD →SRRK and AMGN →SRRK and ARGX →Choose a stock to compare with SRRK →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own SRRK, latest filings →Back to the 13F Explorer →